Business Context and Reporting Period
This Form 8-K Current Report was filed by Accuray Incorporated on February 3, 2025. The filing discloses the appointment of a new senior executive officer effective February 3, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on executive compensation and employment terms.
Material Changes
The primary material change is the appointment of Leonel Peralta as Senior Vice President, Chief Operations Officer. Mr. Peralta joins from Siemens Healthineers, where he served as Vice President, Head of Global Operations for the ultrasound division.
Management Commentary, Risks, and Unusual Items
Executive Compensation and Employment Terms:
The Company entered into an Executive Employment Agreement with Mr. Peralta containing the following terms:
- Base Salary: $450,000 annually.
- Sign-on Bonus: $80,000.
- Annual Cash Incentive: Target amount set at 60% of base salary.
- Performance Bonus: Up to $300,000 based on specific targets.
- Equity Grant: Restricted Stock Units (RSUs) with an aggregate value of $750,000, vesting 25% annually over four years.
Severance Provisions:
The agreement outlines severance benefits for termination without cause or resignation for good reason:
- Standard Termination: 12 months of base salary, prorated target bonus, 12 months of COBRA reimbursement, and outplacement services.
- Change in Control (Double Trigger): If termination occurs within 24 months of a change in control, benefits include 24 months of base salary, 200% of the target bonus, 12 months of COBRA reimbursement, a taxable monthly payment equal to COBRA costs for 12 months, outplacement services, and full acceleration of equity awards.
- Death or Incapacity: Six months of accelerated vesting of outstanding equity awards.
Exhibit Filing: The full text of the Employment Agreement will be filed as an exhibit to the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2025.
Investor Verification Checklist
- Verify the full text of the Executive Employment Agreement when filed in the upcoming Form 10-Q.
- Monitor the vesting schedule and performance targets associated with the $750,000 RSU grant and $300,000 performance bonus.
- Review the Company's cash flow and liquidity position to assess the impact of the $80,000 sign-on bonus and future compensation obligations.
- Track the strategic impact of Mr. Peralta's operational background from Siemens Healthineers and Medtronic on Accuray's global operations.